U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 127

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr4:25128939
GRCh38:
Chr4:25127317
SEPSECSS356L, S441LPontocerebellar hypoplasia type 2DUncertain significance
(Oct 12, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr4:25127349
GRCh38:
Chr4:25125727
SEPSECSS393L, S478LPontocerebellar hypoplasia type 2D, not providedUncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr4:25146396-25146399
GRCh38:
Chr4:25144774-25144777
SEPSECSE343fsPontocerebellar hypoplasia type 2D, not providedPathogenic/Likely pathogenic
(Jun 29, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr4:25157739
GRCh38:
Chr4:25156117
SEPSECSR156QPontocerebellar hypoplasia type 2DUncertain significance
(Mar 24, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr4:25161991
GRCh38:
Chr4:25160369
SEPSECSM1LPontocerebellar hypoplasia type 2DPathogenic
(Oct 1, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr4:25160733
GRCh38:
Chr4:25159111
SEPSECSnot providedBenign
(Aug 10, 2019)
criteria provided, single submitter
7.
GRCh37:
Chr4:25161991
GRCh38:
Chr4:25160369
SEPSECSM1Vnot provided, Pontocerebellar hypoplasia type 2DPathogenic/Likely pathogenic
(Apr 20, 2023)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr4:25146737
GRCh38:
Chr4:25145115
SEPSECSI275VPontocerebellar hypoplasia type 2DUncertain significance
(Jul 22, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr4:25161908
GRCh38:
Chr4:25160286
LOC129992330, SEPSECSnot providedLikely benign
(Aug 20, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr4:25146749
GRCh38:
Chr4:25145127
SEPSECSR271*Inborn genetic diseases, not provided, Pontocerebellar hypoplasia type 2D
Pathogenic/Likely pathogenic
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr4:25127378-25127379
GRCh38:
Chr4:25125756-25125757
SEPSECSH383fsnot provided, Pontocerebellar hypoplasia type 2DPathogenic/Likely pathogenic
(May 9, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr4:25157818
GRCh38:
Chr4:25156196
SEPSECSnot provided, Pontocerebellar hypoplasia type 2DLikely pathogenic
(May 9, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr4:25160588
GRCh38:
Chr4:25158966
SEPSECSR86CPontocerebellar hypoplasia type 2DUncertain significance
(Jul 8, 2020)
criteria provided, single submitter
14.
GRCh37:
Chr4:25160580
GRCh38:
Chr4:25158958
SEPSECSH88QPontocerebellar hypoplasia type 2DUncertain significance
(Aug 13, 2020)
no assertion criteria provided
15.
GRCh37:
Chr4:25157707
GRCh38:
Chr4:25156085
SEPSECSW167RPontocerebellar hypoplasia type 2DUncertain significance
(Aug 14, 2020)
no assertion criteria provided
16.
GRCh37:
Chr4:25153578
GRCh38:
Chr4:25151956
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Apr 21, 2020)
no assertion criteria provided
17.
GRCh37:
Chr4:25146462
GRCh38:
Chr4:25144840
SEPSECSnot providedLikely benign
(Sep 14, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr4:25128886
GRCh38:
Chr4:25127264
SEPSECSA374TPontocerebellar hypoplasia type 2DUncertain significance
(Apr 21, 2020)
no assertion criteria provided
19.
GRCh37:
Chr4:25125837
GRCh38:
Chr4:25124215
SEPSECSL408FPontocerebellar hypoplasia type 2DUncertain significance
(Jan 11, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr4:25125809
GRCh38:
Chr4:25124187
SEPSECSY417Cnot providedUncertain significance
(Jun 9, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr4:25125739
GRCh38:
Chr4:25124117
SEPSECSnot providedLikely benign
(Aug 5, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr4:25125708
GRCh38:
Chr4:25124086
SEPSECSI451VPontocerebellar hypoplasia type 2DUncertain significance
(Apr 21, 2020)
no assertion criteria provided
23.
GRCh37:
Chr4:25125669
GRCh38:
Chr4:25124047
SEPSECSE464*not provided, Pontocerebellar hypoplasia type 2DUncertain significance
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr4:25125606
GRCh38:
Chr4:25123984
SEPSECSA485TPontocerebellar hypoplasia type 2DUncertain significance
(Apr 21, 2020)
no assertion criteria provided
25.
GRCh37:
Chr4:25125598
GRCh38:
Chr4:25123976
SEPSECSK487NPontocerebellar hypoplasia type 2DUncertain significance
(Apr 20, 2020)
no assertion criteria provided
26.
GRCh37:
Chr4:25125547
GRCh38:
Chr4:25123925
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Apr 20, 2020)
no assertion criteria provided
27.
GRCh37:
Chr4:25161875
GRCh38:
Chr4:25160253
LOC129992330, SEPSECSPontoneocerebellar hypoplasia, not provided, Pontocerebellar hypoplasia type 2D
Conflicting interpretations of pathogenicity
(Jul 25, 2023)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr4:25146748
GRCh38:
Chr4:25145126
SEPSECSR271LPontocerebellar hypoplasia type 2DUncertain significance
(Sep 30, 2020)
criteria provided, single submitter
29.
GRCh37:
Chr4:25161897
GRCh38:
Chr4:25160275
SEPSECS, LOC129992330I32RPontocerebellar hypoplasia type 2DUncertain significanceno assertion criteria provided
30.
GRCh37:
Chr4:25125330
GRCh38:
Chr4:25123708
SEPSECSPontocerebellar hypoplasia type 2DBenign
(Apr 27, 2017)
criteria provided, single submitter
31.
GRCh37:
Chr4:25125226
GRCh38:
Chr4:25123604
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr4:25125225
GRCh38:
Chr4:25123603
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr4:25125201
GRCh38:
Chr4:25123579
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr4:25123073
GRCh38:
Chr4:25121451
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr4:25122935
GRCh38:
Chr4:25121313
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
36.
GRCh37:
Chr4:25157827
GRCh38:
Chr4:25156205
SEPSECSPontocerebellar hypoplasia type 2D, not providedConflicting interpretations of pathogenicity
(Jun 22, 2022)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr4:25157825
GRCh38:
Chr4:25156203
SEPSECSPontocerebellar hypoplasia type 2D, not providedConflicting interpretations of pathogenicity
(Oct 19, 2022)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr4:25122682
GRCh38:
Chr4:25121060
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr4:25122637
GRCh38:
Chr4:25121015
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr4:25122632
GRCh38:
Chr4:25121010
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr4:25122587
GRCh38:
Chr4:25120965
SEPSECSPontocerebellar hypoplasia type 2DBenign
(Apr 27, 2017)
criteria provided, single submitter
42.
GRCh37:
Chr4:25156687
GRCh38:
Chr4:25155065
SEPSECSL212Vnot provided, Pontocerebellar hypoplasia type 2DUncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr4:25128878
GRCh38:
Chr4:25127256
SEPSECSnot provided, Pontocerebellar hypoplasia type 2DConflicting interpretations of pathogenicity
(Feb 16, 2021)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr4:25127346
GRCh38:
Chr4:25125724
SEPSECSM394TPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr4:25124545
GRCh38:
Chr4:25122923
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr4:25124522
GRCh38:
Chr4:25122900
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr4:25124431
GRCh38:
Chr4:25122809
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr4:25123962
GRCh38:
Chr4:25122340
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr4:25121683
GRCh38:
Chr4:25120061
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr4:25125802
GRCh38:
Chr4:25124180
SEPSECSF419LPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr4:25125733
GRCh38:
Chr4:25124111
SEPSECSM442IPontocerebellar hypoplasia type 2DUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
52.
GRCh37:
Chr4:25125554
GRCh38:
Chr4:25123932
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Mar 2, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr4:25123916
GRCh38:
Chr4:25122294
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr4:25123905
GRCh38:
Chr4:25122283
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr4:25123894
GRCh38:
Chr4:25122272
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
56.
GRCh37:
Chr4:25160663
GRCh38:
Chr4:25159041
SEPSECSM61VPontocerebellar hypoplasia type 2DUncertain significance
(Aug 1, 2019)
no assertion criteria provided
57.
GRCh37:
Chr4:25146422
GRCh38:
Chr4:25144800
SEPSECSY334HPontocerebellar hypoplasia type 2DUncertain significance
(Nov 15, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr4:25125857
GRCh38:
Chr4:25124235
SEPSECSnot providedLikely benign
(Sep 29, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr4:25161947
GRCh38:
Chr4:25160325
SEPSECSnot provided, Pontocerebellar hypoplasia type 2DBenign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr4:25128988
GRCh38:
Chr4:25127366
SEPSECSnot providedLikely benign
(Oct 29, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr4:25125768
GRCh38:
Chr4:25124146
SEPSECSC431Gnot providedLikely benign
(Oct 21, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr4:25158468
GRCh38:
Chr4:25156846
SEPSECSnot providedLikely benign
(Oct 13, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr4:25146399
GRCh38:
Chr4:25144777
SEPSECSnot providedBenign/Likely benign
(Sep 28, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr4:25146641
GRCh38:
Chr4:25145019
SEPSECSS307GInborn genetic diseases, not providedLikely benign
(Dec 2, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr4:25128986
GRCh38:
Chr4:25127364
SEPSECSnot provided, Pontocerebellar hypoplasia type 2DConflicting interpretations of pathogenicity
(Oct 12, 2022)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr4:25127399
GRCh38:
Chr4:25125777
SEPSECSnot provided, Pontocerebellar hypoplasia type 2DBenign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr4:25158577
GRCh38:
Chr4:25156955
SEPSECSR97*Pontocerebellar hypoplasia type 2D, not providedPathogenic/Likely pathogenic
(Dec 14, 2021)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr4:25125785
GRCh38:
Chr4:25124163
SEPSECSH425RPontocerebellar hypoplasia type 2DUncertain significance
(Apr 27, 2019)
criteria provided, single submitter
69.
GRCh37:
Chr13:77569232
GRCh38:
Chr13:76995097
CLN5C70RPontocerebellar hypoplasia type 2D, Neuronal ceroid lipofuscinosis 5Conflicting interpretations of pathogenicity
(May 27, 2023)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr4:25125666
GRCh38:
Chr4:25124044
SEPSECSR465*not provided, Pontocerebellar hypoplasia type 2D, Spastic ataxia,
not specified
Conflicting interpretations of pathogenicity
(Sep 2, 2022)
criteria provided, conflicting interpretations
71.
GRCh37:
Chr4:25153620
GRCh38:
Chr4:25151998
SEPSECSG256*not providedPathogenic/Likely pathogenic
(May 8, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr4:25157817
GRCh38:
Chr4:25156195
SEPSECSG130Dnot providedUncertain significance
(May 9, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr4:25146714
GRCh38:
Chr4:25145092
SEPSECSnot provided, Pontocerebellar hypoplasia type 2D, not specified
Conflicting interpretations of pathogenicity
(Oct 23, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr4:25157715
GRCh38:
Chr4:25156093
SEPSECSY164Cnot providedUncertain significance
(Aug 21, 2017)
criteria provided, single submitter
75.
GRCh37:
Chr4:25156737
GRCh38:
Chr4:25155115
SEPSECSG195Dnot providedUncertain significance
(Dec 3, 2021)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr4:25156774
GRCh38:
Chr4:25155152
SEPSECSnot providedConflicting interpretations of pathogenicity
(Jun 9, 2022)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr4:25146400
GRCh38:
Chr4:25144778
SEPSECSR341Knot providedUncertain significance
(Mar 8, 2017)
criteria provided, single submitter
78.
GRCh37:
Chr4:25158475
GRCh38:
Chr4:25156853
SEPSECSnot specified, Pontocerebellar hypoplasia type 2D, not provided
Conflicting interpretations of pathogenicity
(Aug 19, 2023)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr4:25158473
GRCh38:
Chr4:25156851
SEPSECSCongenital cerebellar hypoplasia, Arthrogryposis multiplex congenita, Kyphosis,
Spinal rigidity, Severe global developmental delay, Cerebral hypoplasia,
Seizure, Pontocerebellar hypoplasia type 2D
Likely pathogenic
(Jan 1, 2016)
criteria provided, single submitter
80.
GRCh37:
Chr4:25128874
GRCh38:
Chr4:25127252
SEPSECSnot specified, not provided, Pontocerebellar hypoplasia type 2D
Benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr4:25125783
GRCh38:
Chr4:25124161
SEPSECST426Anot provided, Inborn genetic diseases, Pontocerebellar hypoplasia type 2D
Uncertain significance
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr4:25125441
GRCh38:
Chr4:25123819
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr4:25125300
GRCh38:
Chr4:25123678
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
84.
GRCh37:
Chr4:25125282
GRCh38:
Chr4:25123660
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr4:25125199
GRCh38:
Chr4:25123577
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
86.
GRCh37:
Chr4:25125133
GRCh38:
Chr4:25123511
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
87.
GRCh37:
Chr4:25125099
GRCh38:
Chr4:25123477
SEPSECSPontocerebellar hypoplasia type 2DBenign
(Jan 13, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr4:25125098
GRCh38:
Chr4:25123476
SEPSECSPontocerebellar hypoplasia type 2DLikely benign
(Apr 27, 2017)
criteria provided, single submitter
89.
GRCh37:
Chr4:25125083
GRCh38:
Chr4:25123461
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr4:25124943
GRCh38:
Chr4:25123321
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr4:25124941
GRCh38:
Chr4:25123319
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr4:25124915
GRCh38:
Chr4:25123293
SEPSECSPontocerebellar hypoplasia type 2DLikely benign
(Apr 27, 2017)
criteria provided, single submitter
93.
GRCh37:
Chr4:25124872
GRCh38:
Chr4:25123250
SEPSECSPontocerebellar hypoplasia type 2DBenign
(Jan 12, 2018)
criteria provided, single submitter
94.
GRCh37:
Chr4:25124746
GRCh38:
Chr4:25123124
SEPSECSPontocerebellar hypoplasia type 2DBenign
(Apr 27, 2017)
criteria provided, single submitter
95.
GRCh37:
Chr4:25124512
GRCh38:
Chr4:25122890
SEPSECSPontocerebellar hypoplasia type 2DLikely benign
(Apr 27, 2017)
criteria provided, single submitter
96.
GRCh37:
Chr4:25123979
GRCh38:
Chr4:25122357
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
97.
GRCh37:
Chr4:25123939
GRCh38:
Chr4:25122317
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
98.
GRCh37:
Chr4:25123933
GRCh38:
Chr4:25122311
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
99.
GRCh37:
Chr4:25123931
GRCh38:
Chr4:25122309
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr4:25123918
GRCh38:
Chr4:25122296
SEPSECSPontocerebellar hypoplasia type 2DUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination